Dravet Syndrome & Seizures
The role of CBD in management of epilepsy has been investigated in six randomized trials totaling 555 patients. In one particular study, 120 children and young adults with Dravet syndrome were studied. Dravet syndrome is also referred to as severe myoclonic epilepsy of infancy.
It’s a rare and catastrophic form of seizure disorder where patients have seizures that begin in infancy and persist over their lifetime, very difficult to treat drug resistant seizures.
Of these patients, 120 of them were studied over a 14-week treatment period, the median frequency of convulsive seizures reduced from 12.4 to 5.9 per month. That’s a reduction in frequency of seizures of 50% with the addition of CBD compared to placebo.
Worth Noting: Although antiepileptic drugs are the mainstay of therapy, they are often ineffective at reducing seizures in 30% of patients.
There are also multiple adverse effects including blurred vision, tremor, dizziness, nausea, headache, vomiting and fatigue.
For the approximately one-third of patients with epilepsy who are still experiencing seizures despite therapies, new adjunctive therapeutic options can be considered.
DR. MARY CLIFTON
Dr. Mary Clifton is an Internal Medicine doctor in New York City, with 20 years of experience in both the hospital and private practice and is a recognized expert in CBD, Cannabis, and Medical Marijuana.
She is a published researcher, national speaker on women’s health and osteoporosis, and author of four books, and two new soon-to-be-released books on CBD and Cannabis – what you need to know, how to use them and a COOKBOOK to support ease of use.
PS: My Sleep Series has 9 Videos. I’ll be posting one video and it’s transcription per week.
I you need to view all 9 videos in the Sleep Series today, please click here: https://cbdandcannabisinfo.com/sleep-series/